Catherex


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Catherex, a spin-off of Medigene, is a clinical stage immunotherapy company that focuses on the development of T-cell therapy platforms for the treatment of cancer.

Catherex, a spin-off of Medigene, is a clinical stage immunotherapy company that focuses on the development of T-cell therapy platforms for the treatment of cancer.

Company (Acquired)

Phone:

Fax:



Philadelphia,
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Catherex $0M Dec 21, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Catherex Jobs

jobs by Indeed job search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Viral vectors and their use in therapeutic methods Dec 19, 2016 Jan 14, 2020 Patent
Viral vectors and their use in therapeutic methods Oct 27, 2014 Jan 31, 2017 Patent
Viral vectors and their use in therapeutic methods Jun 24, 2013 Oct 28, 2014 Patent
Viral vectors and their use in therapeutic methods Mar 11, 2010 Jun 25, 2013 Patent
Viral vectors and their use in therapeutic methods Jan 10, 2020 Application